Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
General Dhiraj Seth has officially assumed the charge as the 31st Chief of the Army…
National News India Signs Google MoU to Boost Tourism Digitally The Ministry of Tourism has…
In April-May FY2026-27, India's fiscal deficit widened sharply to the ₹1.62 lakh crore and it…
The central government of has reappointed Ravi Agrawal as the Chairman of the Central Board…
In the year 2025, India's unemployment rate fell to 3.1% and it is the lowest…
The Ministry of Tourism has signed the Memorandum of Understanding (MoU) with Google India Pvt.…